Ziccum Updates

Ziccum CEO at Swedish Ministry for Foreign Affairs for a Roundtable Discussion

Ziccum CEO Ann Gidner was invited to the Swedish Ministry for Foreign Affairs for a roundtable discussion on the important topic of “Leveraging Technology and Innovation to Ensure Every Child is Vaccinated”. The gathering included the S...

Ziccum’s LaminarPace featured in Omni and Omni Ekonomi in Swedish

We are happy to share Omni’s article in Swedish highlighting Ziccum’s LaminarPace® technology. The article focuses on the remarkable potential of LaminarPace®, which enables the drying of fragile mRNA drugs and vaccines while eliminat...

Ziccum Presents in Swedish at Stora Aktiedagarna, 27 November, Stockholm

Ziccum CEO Ann Gidner gave a compelling presentation at Stora Aktiedagarna, Stockholm on 27th of November showcasing Ziccum’s groundbreaking LaminarPace technology, which transforms fragile liquid biologics into robust, thermos...

Ziccum featured by Aktiespararna in Swedish

We are pleased to share Aktiespararna’s article highlighting Ziccum’s LaminarPace® technology. The article focuses on Ziccum’s great potential when it comes to helping biopharmaceuticals to realization and the mRNA revolution, inform...

Ziccum CEO’s Presentation at the Biostock Life Science Summit

On November 21st in Lund, Ziccum CEO Ann Gidner delivered an engaging presentation at BioStock Life Science Summit, highlighting the innovative LaminarPace technology, which garnered significant interest from investors and life s...

Ziccum CEO at The Future of Healthcare – Going Global with Citi, 14 November, Copenhagen

Ziccum CEO Ann Gidner was pleased to join The Future of Healthcare – Going Global with Citi on November 14th in Copenhagen. This exclusive, invite-only event serves as a gathering for senior executives from life sciences, biotechnology, a...

Ziccum Gathers for an Inhaled Biologics Workshop

Ziccum gathered for an insightful and productive Inhalation Workshop on November 12th. The meeting was focused on LaminarPace’s unique features particularly well suited for inhaled biopharmaceuticals. Strong, new data has confi...

Ziccum at Bio Europe, 4-6 November, Stockholm

Ziccum CEO Ann Gidner, along with Business Manager Ilkim Atmaca, participated in Bio-Europe, held in Stockholm, Sweden from November 4–6, 2024. As Europe’s leading life science partnering event, Bio-Europe provided an excellent platform...

Ziccum Presents at the Biostock Life Science Summit 2024, Lund

To explore more about Ziccum’s LaminarPace technology and learn how it cuts costs, enables new treatments and allows for particle engineering perfectly suitable for inhalation, please attend Ziccum’s presentation at the Biostock Life Sc...

Ziccum at Nordic Life Science Days, 18-19 September, Malmö

Ziccum participated in the Nordic Life Science Days held in Malmö on 18-19 September 2024. This premier event brought key innovators from across the European life science industry together. Scientific Director Fabrice Rose: "Attending N...

Meet Ziccum at Bio-Europe, 4-6 November, Stockholm

Join Ziccum at Bio-Europe, taking place on November 4-6, 2024 in Stockholm. Please discover how LaminarPace formulation + drying technology is revolutionizing biopharmaceuticals to convert fragile liquid biologics into robust, thermostable,...

Watch Ziccum’s Interview at Biostock Investing in Life Science: From Seed to Success

Ziccum CEO Ann Gidner shared insights in an interview at BioStock Investing in Life Science: From Seed to Success, held in Stockholm on September 12th, 2024, discussing the groundbreaking LaminarPace technology that fully unlocks...

Watch CEO Presentation at Biostock Investing in Life Science: From Seed to Success

On September 12th in Stockholm, Ziccum CEO Ann Gidner delivered a compelling presentation at BioStock Investing in Life Science: From Seed to Success, garnering strong interest from life science leaders and investors. The pres...

We are excited to share a new article from Dagens Industri that highlights why Ziccum’s LaminarPace technology is revolutionary for the pharmaceutical industry, and how groundbreaking findings on increased mRNA activity could mark the beg...

Ziccum Presentation at RNA Leaders Draws Significant Interest

Ziccum CEO Ann Gidner’s presentation at RNA Leaders in San Diego on September 4th, 2024, drew significant attention from key stakeholders in the RNA development community. It addressed a critical challenge in the mRNA field: how to create...

Ziccum Takes Part at the Future of Swedish & Danish Life Science, 29 August, Lund

On August 29th, 2024, Ziccum participated in the Future of Swedish & Danish Life Science event in Lund. This well-attended gathering brought together key players from the Swedish and Danish life science sectors, promoting collaboration ...

Ziccum Takes Part at New Updates in Drug Formulation & Bioavailability, 28 August, Copenhagen

Ziccum attended the New Updates in Drug Formulation & Bioavailability event in Copenhagen on August 28th, 2024. This event provides a dynamic platform for bringing together R&D professionals and pharma industry representatives, disc...

Ziccum at the Future of Swedish & Danish Life Science, 29 August, Lund

Ziccum’s unique LaminarPace technology transforms delicate liquid biotherapeutics into robust, thermostable, and high-yield dry powders without exposing them to extreme temperatures, stress, or degradation. This innovative approach ensure...

Meet Ziccum at Nordic Life Science Days, 18-19 September, Malmö

Ziccum's unique LaminarPace technology unleashes the full potential of mRNA and opens the door to entirely new mRNA treatments. This formulation and ambient drying technology transforms delicate liquid biologics into robust, thermostable, h...

Ziccum Presents at RNA Leaders USA Congress, San Diego, USA

Join Ziccum at RNA Leaders USA Congress on September 4 – 5, 2024, in San Diego, USA and attend our presentation on September 4, 2024, at 16.00 covering the topic: "Enabling the Full Potential of mRNA – with Robust, Particle Engineered, ...

Ziccum goes live on Dagens Industri

We are very pleased to announce that Ziccum has gone live at DI.se. Please find a dedicated company page tracking the company’s stock performance, access to reports, investor relations announcements, and a company profile, including a ...

Ziccum’s CEO Presenting at BioStock 2024 Global Forum

Ziccum’s CEO Ann Gidner delivered a presentation at BioStock 2024 Global Forum on May 30th, 2024 in Lund, Sweden, outlining the disruptive potential of LaminarPaceTM, a formulation and drying technology for ...

Ziccum welcomes new Chairman of the Board and new Board member, while thanking Chairman and founder stepping down

Following a highly valuable tenure, Ziccum’s co-founder and former Chairman Fredrik Sjövall is handing over to Jonas Ekblom, who has been elected Chairman of the Board at Ziccum’s AGM on May 29th, during which Ziccum also added a new m...

Ziccum presentation well-received at BioStock Global Partnering Forum

Ziccum CEO Ann Gidner delivered a well-received presentation at BioStock Global Partnering Forum in Lund, Sweden on May 30th, sparking new interest and dialogues with biotech leaders and investors. Ziccum’s LaminarPace was presented, a...

Ziccum follows up on dialogues at BIO-Europe Spring, Barcelona

Ziccum CEO Ann Gidner and Chairman Fredrik Sjövall are joining Europe’s leading biotech and biopharma companies in Barcelona at the BIO-Europe Spring Partnering conference, 18-20 March. Ziccum is following up on interesting pipeline d...

Ziccum takes part in 5th Biologics World Nordics Forum, Copenhagen

On 5th March 2024, Ziccum management representatives joined over 100 Biotech companies represented at the 5th Biologics World Nordics Forum in central Copenhagen. The well-attended event brought together biopharmaceuticals dev...

Join Ziccum at BIO-Europe Spring, 18 – 20 March, Barcelona

Solving stability and enabling new drug delivery options for next-generation Biologics is key to unlocking a vast potential. How could it work for your Biologic or mRNA project?  Meet Ziccum CEO Ann Gidner and Chairman Fredrik Sjövall at ...

Ziccum CEO to present at Capital Markets Day, Life Science

On Tuesday March 12, 10.15 – 10.45, Ziccum CEO Ann Gidner will present the company’s unique technology for formulating and drying biologics and vaccines as robust thermostable dry powders at Stockholm Corporate Finance’s Capital Marke...

Meet Ziccum at 5th Biologics World Forum, Copenhagen, 7th March

Interested in how your next-generation biotherapeutics can be formulated as stable dry powders requiring no cryogenic freezing or delicate handling? Meet Ziccum CEO Ann Gidner, COO Xavier Turon and Scientific Director Fabrice Rose to he...

Ziccum CEO presentation generates keen interest at Europe’s largest industry mRNA event

Ziccum CEO Ann Gidner presented Ziccum’s robust new mRNA/LNP results, and Scientific Director Fabrice Rose hosted a well-attended poster session at the mRNA Summit. CEO Ann Gidner delivered a detailed 30-minute presentation to an audie...

Join Ziccum Chairman at a Live Digital Press Conference and Q&A, Tues Jan’ 23 1300

Put your questions on Ziccum’s new share issue and financing agreement to Chairman Fredrik Sjövall at a live digital Press Conference with Direkt Studios and Investor Targeting. The event will take place in Swedish. Investors can subm...

Ziccum to present further positive mRNA/LNP data at Europe’s largest industry mRNA event

Join Ziccum, as CEO Ann Gidner presents the company’s excellent new mRNA/LNP results, generated in both internal and partnered projects, at the mRNA-based Therapeutics Summit Europe 2024 in Berlin. Ziccum is represented by CEO Ann Gidn...

MT 2023: Ziccum Chief Operating Officer Xavier Turon on an industrious 2023

Throughout the winter break Ziccum Management Team members share their reflections on the year in our series MT 2023. Today, COO Xavier Turon on his first months with the company. Arriving at Ziccum in October 2023 was an exciting journe...

MT 2023: Ziccum Scientific Director Fabrice Rose on an intensive 2023

Throughout the winter break Ziccum Management Team members are sharing their reflections on the year in our series MT 2023. Today, Scientific Director Fabrice Rose on Ziccum’s intensive scientific year and ongoing studies. "The standou...

MT 2023: Ziccum CFO Johny Humaloja on a standout 2023

Throughout the winter break Ziccum Management Team members are sharing their reflections on the year in our series MT 2023. Today, CFO Johny Humaloja on Ziccum’s financial performance in 2023 and what lies ahead. "This year Ziccum has ...

Join MT 2023 – Ziccum Management Team Review 2023

Throughout the winter break Ziccum Management Team members will be sharing their key learnings from the year, and what lies ahead, in our new series MT 2023. Today, CEO Ann Gidner introduces the series. "This year we have strengthened th...

Ziccum Christmas party crowns a successful year

On Friday 15 December, Ziccum crowned a successful year with a 2023 summary and seasonal celebration. The Management Team presented a strategic review of 2024’s milestones, and the year ahead. Colleagues then enjoyed a ‘Glöggmi...

Ziccum presents at industry webinar ‘Inhaled Biologics’

On Dec’ 11 Ziccum won extensive interest in its unique technology for formulating and drying liquid biologics, LaminarPace, from a specialist audience of international  inhaled drug development scientists from Europe, the US and Asia. Th...

Ziccum heads West in 2024 to J P Morgan Week & Longwood Healthcare Leaders CEO Conference

Ziccum heads West in 2024, Jan 6 – 11, San Francisco. Book now to meet Ziccum and hear the latest news and data on our thermostable mRNA/LNP projects and unique formulation & drying technology, that turns liquid biologics into robust ...

Ziccum move dialogues to next level at NLS Copenhagen

Ziccum had an intensive schedule of meetings at Nordic Life Science, Copenhagen November 29 – 30. CEO Ann Gidner and Chairman Fredrik Sjövall were invited to partnering meetings with new interested prospects and attended valuable foll...

Ziccum CEO: new BioStock presentation

A new presentation by Ziccum CEO Ann Gidner describes how new robust formulations of mRNA/LNP vaccines and therapeutics that do not require cryogenic storage or special handling can be generated by the company’s unique technology with par...

Ziccum in ‘Inhaled Biologics’ live webinar with KOL Assoc Prof. Per Gerde

Are you a formulation scientist trying to develop new, more stable formulations of biopharmaceuticals? On Monday Dec 11 Ziccum experts are special guests at a live scientific webinar on ‘Inhaled Biologics’ with inhalation Key Opinion Le...

Meet Ziccum at Nordic Life Science Days 29-30 Nov’, Copenhagen

Meet Ziccum CEO Ann Gidner and Chairman Fredrik Sjövall at Nordic Life Science Days 29-30 November, Copenhagen. Discuss new stability and delivery solutions for next-generation Biotherapeutics. Want to expand what's possible for your d...

Ziccum industrial development workshop at Research Center for Pharmaceutical Engineering, Graz

On Thursday November 9 Ziccum were at an all-day workshop at the Research Center for Pharmaceutical Engineering in Graz, a global leader in pharmaceutical process engineering, organized by advanced process engineering simulation experts Sim...

Intensive interactions for Ziccum at largest ever BIO-Europe event

Ziccum CEO Ann Gidner and Chairman Fredrik Sjövall enjoyed a packed schedule of quality meetings at the BIO-Europe Partnering Conference this week, with close to 6,000 pharma and biopharma professionals attending. The event ran from Nov...

Ziccum attends BIO-Europe 2023 in Munich

Connect with Ziccum CEO Ann Gidner and Chairman Fredrik Sjövall at BIO-Europe Nov 6-8, Munich, to discover our unique formulation and drying technology LaminarPace, new external validation of our data, and our most recent deal with a major...

LaminarPace features in textbook showcasing new vaccine drying technologies

LaminarPace, Ziccum's unique drying and formulation technology for biologics, has been featured in "Spray Drying of Vaccines - from Laboratory Research to Industrial Applications" by Dr. Cordin Arpagaus. The book argues that emerging altern...

Ziccum at World Vaccine Congress Barcelona

Ziccum Scientific Director Fabrice Rose and Quality Specialist Fatemeh Norouzi attended the World Vaccine Congress in Barcelona, October 16 - 19, spreading the word on Ziccum's unique drying and formulation technology LaminarPace and how i...

Ziccum and ZHAW in intensive 3D modelling workshop

In an intensive workshop on Friday October 14 at Ziccum's facilities in Lund,  Ziccum and its visiting partner team from the  Zurich University of Applied Sciences' Institute of Computational Physics powered ahead with the cutting-edge pr...